Company / Working Capital per Share
Tandem Diabetes Care Working Capital per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$5.67
FY2025
5-year range
$5.67 / $10.90
FY2021-FY2025
Trend
-22.2%
vs FY2024
Sector context
#75 of 158
Health Care
What the data says
At $5.67, Tandem Diabetes Care's working capital per share ranks #75 of 158 in the Health Care sector. Working Capital per Share has declined for 4 consecutive years, from $10.90 in FY2021 to $5.67 in FY2025.
Based on SEC 10-K filings.
5.67 in FY2025 with a 5-year CAGR of -8.8%.
Declined from $8.57 to $5.67 over the past 2 years.
Health Care sector context is included.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- -19.2%
- 5-Year CAGR
- -8.8%
- 10-Year CAGR
- -
Sector benchmark
#75 of 158 in Health CareTop 47% of 158This company $5.67 Sector average $24.43
▼
-76.8% below sector average
Key checks
Key Insights
- Tandem Diabetes Care's working capital per share has declined for 4 consecutive years.
- In FY2025, working capital per share decreased 22.2% year-over-year.
- Ranks #75 out of 158 companies in the Health Care sector.
- Peak working capital per share was recorded in FY2018.
Company context
Key Data Points
- Altman Z-Score -0.32 (distress zone, below 1.8 threshold)
- Negative profit margin: -20.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $5.67 | -22.2% |
| FY2024 | $7.28 | -15.0% |
| FY2023 | $8.57 | -20.1% |
| FY2022 | $10.73 | -1.6% |
| FY2021 | $10.90 | +21.4% |
| FY2020 | $8.98 | +192.4% |
| FY2019 | $3.07 | -74.4% |
| FY2018 | $12.02 | +33.1% |
| FY2017 | $9.03 | +350.5% |
| FY2016 | $2.00 | -41.1% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026